Sales and Marketing

Showing 15 posts of 11526 posts found.

AZ-BMS diabetes drug impresses in phase III trials

October 1, 2010 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes

AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …

BMS poaches AZ’s head of global medical affairs

October 1, 2010 Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …

J&J chief admits mistakes at Congressional hearing

October 1, 2010 Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …

Doctors express serious doubts about health reforms

October 1, 2010 Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …

Caelyx rights to revert back to Janssen

September 30, 2010 Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
Herceptin packs

New Herceptin data sways NICE

September 30, 2010 Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …

Termeer exit could help Sanofi

September 30, 2010 Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …

Nestlé to pioneer ‘health science nutrition’

September 29, 2010 Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …
EuropeanParliamentWEB

Europe votes for patients’ access to information

September 29, 2010 Medical Communications, Sales and Marketing Europe, medicines information

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …

Outcomes based measures for Pharma new commercial models

September 29, 2010 Sales and Marketing Kinapse, White paper

It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …

New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale

September 29, 2010 Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …

European Commission eyes pharma ethics

September 27, 2010 Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …

Late stage cancer drug failure for AstraZeneca

September 27, 2010 Sales and Marketing AstraZeneca, prostate cancer, zibotentan

AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …

AZ’s antiplatelet recommended for European approval

September 27, 2010 Sales and Marketing Brilinta, Brilique, Brillinta, Possia

AstraZeneca’s oral antiplatelet treatment Brilique has received a positive opinion from a key European advisory committee. A marketing authorisation for …

Europe committee rejects MS treatment Movectro

September 24, 2010 Sales and Marketing Cladribine, Merck Serono Movectro

The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
The Gateway to Local Adoption Series

Latest content